SUFENTA PRESERVATIVE FREE

Sufenta Preservative Free Adverse Events Reported to the FDA Over Time

How are Sufenta Preservative Free adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Sufenta Preservative Free, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Sufenta Preservative Free is flagged as the suspect drug causing the adverse event.

Most Common Sufenta Preservative Free Adverse Events Reported to the FDA

What are the most common Sufenta Preservative Free adverse events reported to the FDA?

Anaphylactic Shock	54 (6.98%)
Renal Failure Acute	42 (5.43%)
Haematuria	28 (3.62%)
Oliguria	25 (3.23%)
Hypotension	23 (2.97%)
Bronchospasm	22 (2.84%)
Erythema	19 (2.45%)
Circulatory Collapse	16 (2.07%)
Cytolytic Hepatitis	15 (1.94%)
Septic Shock	15 (1.94%)
Acute Pulmonary Oedema	14 (1.81%)
	Show More
Cardiac Arrest	14 (1.81%)
Lymphopenia	14 (1.81%)
Shock	13 (1.68%)
Tachycardia	13 (1.68%)
Pleural Effusion	12 (1.55%)
Respiratory Failure	12 (1.55%)
Product Quality Issue	11 (1.42%)
Rash	10 (1.29%)
Cardiac Failure	9 (1.16%)
Oxygen Saturation Decreased	9 (1.16%)
Agranulocytosis	8 (1.03%)
Cardio-respiratory Arrest	8 (1.03%)
Generalised Erythema	8 (1.03%)
Coma	7 (.9%)
Haemodynamic Instability	7 (.9%)
Haemolysis	7 (.9%)
Pancytopenia	7 (.9%)
Stevens-johnson Syndrome	7 (.9%)
Blood Creatinine Increased	6 (.78%)
Bradycardia	6 (.78%)
Cyanosis	6 (.78%)
Histiocytosis Haematophagic	6 (.78%)
Renal Failure	6 (.78%)
Respiratory Acidosis	6 (.78%)
Sinus Tachycardia	6 (.78%)
Agitation	5 (.65%)
Blood Pressure Decreased	5 (.65%)
Condition Aggravated	5 (.65%)
Multi-organ Failure	5 (.65%)
Rash Maculo-papular	5 (.65%)
Respiratory Distress	5 (.65%)
Toxic Skin Eruption	5 (.65%)
Acute Respiratory Distress Syndrome	4 (.52%)
Cholestasis	4 (.52%)
Dysarthria	4 (.52%)
Enterobacter Infection	4 (.52%)
Hyperhidrosis	4 (.52%)
Hypoxia	4 (.52%)
Pallor	4 (.52%)
Proteinuria	4 (.52%)
Anaphylactic Reaction	3 (.39%)
Anuria	3 (.39%)
Bacteroides Infection	3 (.39%)
Cheilitis	3 (.39%)
Drug Exposure During Pregnancy	3 (.39%)
Drug Interaction	3 (.39%)
Haemodialysis	3 (.39%)
Injection Site Thrombosis	3 (.39%)
Malaise	3 (.39%)
Pigmentation Disorder	3 (.39%)
Pruritus	3 (.39%)
Rash Erythematous	3 (.39%)
Rash Generalised	3 (.39%)
Respiratory Disorder	3 (.39%)
Skin Test Negative	3 (.39%)
Splenomegaly	3 (.39%)
Tryptase Increased	3 (.39%)
Vasoplegia Syndrome	3 (.39%)
Abdominal Pain	2 (.26%)
Agitation Postoperative	2 (.26%)
Arrhythmia	2 (.26%)
Cauda Equina Syndrome	2 (.26%)
Confusional State	2 (.26%)
Conjunctivitis	2 (.26%)
Drug Ineffective	2 (.26%)
Drug Rash With Eosinophilia And Sys...	2 (.26%)
Dyspnoea	2 (.26%)
Electrocardiogram Qrs Complex Prolo...	2 (.26%)
Encephalopathy	2 (.26%)
Haemoglobin Decreased	2 (.26%)
Heparin-induced Thrombocytopenia	2 (.26%)
Hepatitis Acute	2 (.26%)
Hepatocellular Injury	2 (.26%)
Histamine Level Increased	2 (.26%)
Hyperammonaemia	2 (.26%)
Hypercapnia	2 (.26%)
Hyperkalaemia	2 (.26%)
Hypersensitivity	2 (.26%)
Hyperthermia	2 (.26%)
Inflammation	2 (.26%)
Metabolic Acidosis	2 (.26%)
Myocardial Infarction	2 (.26%)
Pyelocaliectasis	2 (.26%)
Pyrexia	2 (.26%)
Renal Tubular Necrosis	2 (.26%)
Sinoatrial Block	2 (.26%)
Tachypnoea	2 (.26%)
Thrombocytopenia	2 (.26%)
Toxic Epidermal Necrolysis	2 (.26%)
Troponin Increased	2 (.26%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Sufenta Preservative Free, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sufenta Preservative Free is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Sufenta Preservative Free

What are the most common Sufenta Preservative Free adverse events reported to the FDA?

Renal Disorders	82 (10.59%)
Epidermal And Dermal Conditions	72 (9.3%)
Allergic Conditions	62 (8.01%)
Cardiac Arrhythmias	54 (6.98%)
Decreased And Nonspecific Blood Pre...	52 (6.72%)
Respiratory	45 (5.81%)
Urinary Tract Signs	33 (4.26%)
Hepatic And Hepatobiliary	26 (3.36%)
Bronchial Disorders	24 (3.1%)
White Blood Cell	22 (2.84%)
Lower Respiratory Tract Disorders	19 (2.45%)
	Show More
Infections - Pathogen Unspecified	17 (2.2%)
Neurological	16 (2.07%)
Pleural	12 (1.55%)
Product Quality Issues	11 (1.42%)
Vascular	11 (1.42%)
Cardiac And Vascular Investigations	10 (1.29%)
Heart Failures	10 (1.29%)
Metabolic, Nutritional And Blood Ga...	10 (1.29%)
Bacterial Infectious	9 (1.16%)
Procedural And Device Related Injur...	8 (1.03%)
Anemias Nonhemolytic And Marrow Dep...	7 (.9%)
Hemolyses And Related Conditions	7 (.9%)
Immunology And Allergy	7 (.9%)
Cardiac Disorder Signs	6 (.78%)
Hematopoietic Neoplasms	6 (.78%)
Renal And Urinary Tract Investigati...	6 (.78%)
Therapeutic And Nontherapeutic Effe...	6 (.78%)
Administration Site Reactions	5 (.65%)
Anxiety Disorders	5 (.65%)
Body Temperature Conditions	5 (.65%)
Enzyme	5 (.65%)
Hematology Investigations	5 (.65%)
Chemical Injury And Poisoning	4 (.52%)
Electrolyte And Fluid Balance Condi...	4 (.52%)
Gastrointestinal Signs	4 (.52%)
Oral Soft Tissue Conditions	4 (.52%)
Platelet	4 (.52%)
Skin Appendage Conditions	4 (.52%)
Spleen, Lymphatic And Reticulendoth...	4 (.52%)
Acid-base	3 (.39%)
Angiedema And Urticaria	3 (.39%)
Deliria	3 (.39%)
Hematological And Lymphoid Tissue T...	3 (.39%)
Hepatobiliary	3 (.39%)
Neuromuscular	3 (.39%)
Pigmentation	3 (.39%)
Coronary Artery	2 (.26%)
Encephalopathies	2 (.26%)
Nephropathies	2 (.26%)
Ocular Infections, Irritations And ...	2 (.26%)
Protein And Amino Acid Metabolism	2 (.26%)
Protein And Chemistry Analyses	2 (.26%)
Seizures	2 (.26%)
Spinal Cord And Nerve Root	2 (.26%)
Therapeutic Procedures And Supporti...	2 (.26%)
Central Nervous System Infections A...	1 (.13%)
Disturbances In Thinking	1 (.13%)
Exocrine Pancreas Conditions	1 (.13%)
Gastrointestinal Hemorrhages	1 (.13%)
Mental Impairment	1 (.13%)
Movement Disorders	1 (.13%)
Muscle	1 (.13%)
Myocardial	1 (.13%)
Neonatal Respiratory	1 (.13%)
Peripheral Neuropathies	1 (.13%)
Renal And Urinary Tract Therapeutic...	1 (.13%)
Respiratory Tract Therapeutic Proce...	1 (.13%)
Suicidal And Self-injurious Behavio...	1 (.13%)
Upper Respiratory Tract Disorders	1 (.13%)
Vascular Hemorrhagic	1 (.13%)
Vascular Hypertensive	1 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Sufenta Preservative Free, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sufenta Preservative Free is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.